A comparative randomized, open-label, rater-blinded study of paliperidone palmitate and risperidone long-acting injectable therapy in patients with schizophrenia

被引：0
|
作者：
Li, H. [1 ]
Rui, Q.
Ning, X.
Xu, H.
Gu, N. [1 ]
机构：
[1] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [41] An open-label trial of risperidone long-acting injectable in the treatment of subject with recent onset psychosis
    Emsley, R.
    Schreiner, A.
    Koen, L.
    Oosthuizen, P.
    Niehaus, D.
    Rabinowitz, J.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A100 - A100
  • [42] An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
    Kumar, Pattath Narayanan Suresh
    Suresh, Rohith
    Menon, Vikas
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2023, 45 (01) : 19 - 25
  • [43] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Kim, H.
    Hong, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S456
  • [44] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Ciwoniuk, M.
    Godlewska, B. R.
    Olajossy-Hilkesberger, L.
    Olajossy, M.
    Marmurowska-Michalowska, H.
    Limon, J.
    Landowski, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S457
  • [45] Efficacy and safety of long-acting injectable risperidone in patients with schizophrenia
    Bouhours, P
    Schreiner, A
    Rendall, MR
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 171
  • [46] Improvement in Prolactin and Sexual Side Effects in Patients With Schizophrenia Who Switched From Paliperidone Palmitate or Risperidone Long-Acting Injectable to Aripiprazole Lauroxil
    Kelly, Deanna
    Claxton, Amy
    Bidollari, Ilda
    Du, Yangchun
    Young, Matthew
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S373 - S373
  • [47] Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison
    Fu, Dong-Jing
    Bossie, Cynthia A.
    Sliwa, Jennifer K.
    Ma, Yi-Wen
    Alphs, Larry
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (01) : 45 - 55
  • [48] Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
    Gaebel, Wolfgang
    Schreiner, Andreas
    Bergmans, Paul
    de Arce, Rosario
    Rouillon, Frederic
    Cordes, Joachim
    Eriksson, Lars
    Smeraldi, Enrico
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (12) : 2367 - 2377
  • [49] Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
    Javier Quintero
    Itziar Oyagüez
    Beatriz González
    Ignacio Cuervo-Arango
    Ignacio García
    Miguel Angel Casado
    Clinical Drug Investigation, 2016, 36 : 479 - 490
  • [50] Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
    Quintero, Javier
    Oyaguez, Itziar
    Gonzalez, Beatriz
    Cuervo-Arango, Ignacio
    Garcia, Ignacio
    Angel Casado, Miguel
    CLINICAL DRUG INVESTIGATION, 2016, 36 (06) : 479 - 490
12345